Molteni Therapeutics

Molteni Therapeutics products are made to sustain and improve the patient’s quality of life, to help physicians in the clinical practices, to meet the unmet medical needs

Read more

Molteni Therapeutics

Molteni Therapeutics follows the highest quality standards for the design, development and production of its innovative Medical Devices

Read more

Molteni Therapeutics

Molteni Therapeutics always strives to exceed customer expectations and keep patient safety and products’ quality as key priorities.

Read more

Molteni Therapeutics Patents

Patents List (updated February 2018)

  • Zinc phthalocyanines and corresponding conjugates, their preparation and use in photodynamic therapy and as diagnostic agents. EP patent n. 0906758 (2011); US patent n. 5,965,598 (1999); CA patent n. 2,245,066 (2009).

  • Substituted metal-phthalocyanines, their preparation and use thereof. EP patent n. 1164135 (2004); US patent n. 7,144,879 (2006); US patent n. D 7,749,991 (2010); AU patent n.2001272463 (2006); JP patent n. 5137282 (2012).

  • Metal substituted non centrosimmetrical phthalocyanine analogues, their preparation and use in photodynamic therapy and in vivo diagnostic. EP patent n. 1381611 (2005); US patent n. 7,153,841 (2006); AU patent n. 2002341034 (2007); CN patent n. ZL02806846.7 (2007).

  • Antibacterial compositions comprising metal phthalocyanine analogues. EP patent n. 1356813 (2005); US patent n. 8,664,382 (2014); AU patent n. 2003224100 (2007); CN patent n. ZL03809337.5 (2007).

  • Separation of regioisomers of metal phthalocyanines. EP patent n. 1444236 (2007); US patent n. 7,265,100 (2007); AU patent n. 2002351793 (2011); CN patent n. ZL02821738.1 (2008); CN patent n. D ZL2007101939 (2011).

  • Phthalocyanine derivatives, process for their preparation, pharmaceutical compositions containg them and their use.EP patent n. 1883641 (2008); US patent n. 8,067,404 (2011); AU patent n. 2006243217 (2011); JP patent n. 5103381 (2012).

  • Process for preparing chlorides of phthalocyanine derivatives comprising at least a quaternary ammonium group. EP patent n. 1883640 (2009); US patent n. 8,242,262 (2012); AU patent n. 2006243214 (2011); CN patent n. ZL2006800152 (2011).

  • Self sterilizing products. EP patent n. 1904109 (2013); US patent n. 8,741,264 (2014); AU patent n. 2006263834 (2011); CN patent n. ZL2006800240 (2011).

  • Phthalocyanine derivatives consisting of mixture of 4 isomers. EP Granted 10 771 346.3. EP patent n. 2459567 (2015); US application n. 13/387,407 (2010); AU patent n. 2010277539 (2014); CN patent n. ZL2010800331 (2015).

© 2018 Molteni Therapeutics s.r.l, sede legale: Via I. Barontini, 8 - Loc. Granatieri , 50018 Scandicci (FI) ITALY
Phone +39 0557361285 – Fax +39 055 7361288 – P.IVA e C.F. 01195920523